Last reviewed · How we verify

NCT05058326: MANOPRESS

Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women

Completed Last updated 31 March 2022
What this trial tests

trial testing Portable endoanal manometry in Fecal Incontinence in 41 participants. Completed in 1 October 2021.

Timeline
20 September 2020
Primary endpoint
1 October 2021
1 October 2021

Quick facts

Lead sponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta
StatusCompleted
Study typeOBSERVATIONAL
Enrollment41
Start date20 September 2020
Primary completion1 October 2021
Estimated completion1 October 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Who can join

18 and older, female only, with Fecal Incontinence or Anal; Sphincter, Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to stablish a correlation between fecal incontinence severity scales (Wexner \& St. Mark's) and manometric values obtained using the Anopress® portable manometry and values obtained using endoanal ultrasound in women with fecal incontinence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fecal Incontinence

Currently open trials in the same condition.

Other Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05058326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing